Drug use evaluation of vancomycin based on hospital policy and published guidelines

Australian Journal of Hospital Pharmacy

Volumn 28, Issue 6, 1998, Pages 394-399

  Ioannides Demos, Lisa L ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; VANCOMYCIN;

ARTICLE; AUSTRALIA; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; DOSE CALCULATION; DRUG COST; DRUG INDICATION; DRUG UTILIZATION; HEALTH CARE POLICY; HOSPITAL ADMISSION; HOSPITAL PHARMACY; HUMAN; PENICILLIN ALLERGY; PRACTICE GUIDELINE; TEACHING HOSPITAL; UNITED STATES;

EID: 0032411587     PISSN: 03106810     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr1998286394     Document Type: Article

References (5)

1. Ena J, Dick RW, Jones RN, Wenzel RP.The epidemiology of intravenous vancomycin usage in a university hospital. JAMA 1993; 269: 1126-33.
2. Quale J, Landman D, Atwood E, Kreisworth B, Willey BM, DitoreV, et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control 1996; 24: 372-9.
3. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, et al. Vancomycin resistant enterococci alert: vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-33.
4. Handwerger S, Raucher B, Altarac D, Monca J, Marchione S. Singh KV, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin Infect Dis 1993; 16: 750-5.
5. Hiramatsu K, Hanaki H, Ino T,Yabuta K, Oguri T,Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-6.